AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2011
Aug 9, 2011
31676_dirs_2011-08-09_f35464e0-0f7a-4331-b3f5-e0be260d4a5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2011-08-08
Reporting Person: DONENBERG PHILIP B (Sr. VP of Finance, CFO & Secy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-08 | Common Stock | P | 1000 | $2.23 | Acquired | 44322 | Direct |
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3